Daniel Bergner felt frustrated and helpless back when one of his closest family members — his brother — was diagnosed as having bipolar disorder. So Bergner decided to report out other possibilities for his brother’s healing.
Intelligent. Optimistic. Curious.
Science
Maia Szalavitz is an expert in addiction. She is also someone who has experienced it personally as a young woman. It was during that time that she came upon a concept that is only now changing how we think about recovery on a mass scale —harm reduction.
After a health scare, Annabel Abbs promised herself she'd make a real effort to walk every day. She fell in love with walking, even began taking multi-week walking vacations. And then she discovered she wasn't the only one — there's a hidden history of great women walkers from the past. So she decided to tell their stories.
A decade ago, Lou Lukas took part in one of the first trials of psilocybin-assisted therapy. Today, she's a palliative medicine physician and an advocate for psychedelic-assisted therapy – especially for people living in fear near the end of life.
Bill Linton is on a mission. He wants to get FDA approval for using psychedelics to treat depression and addiction. So he co-founded his own nonprofit psychedelic center, Usona Institute, to help revolutionize the treatment of mental illness.
A psychedelic research center in Wisconsin is gearing up to manufacture enough medical-grade psilocybin to supply the world. Steve Paulson went to Usona Insitute to see where the magic's made, and got a peek inside the lab of chemist Alex Sherwood.
Psychedelics show remarkable promise for treating depression, addiction and PTSD. They just might revolutionize the treatment of mental illness.
Pages
